Skip to content

Pfizer Inc (PFE) stock: revenue, earnings & dividend

Pfizer Inc (PFE, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PFE · NYSE Pharma & Biotech US-NY

Key figures

Fiscal year
2025
Revenue
62.6 bn $
Revenue growth
-1.7 %
Revenue growth 5y (p.a.)
8.5 %
Net income
7.77 bn $
Net margin
12.4 %
Operating margin
–
Earnings per share (diluted)
1.36 $
Dividend per share
1.72 $
Payout ratio
126.5 %
Consecutive dividend years
16 years
Consecutive dividend raises
15 years
Dividend growth 5y (p.a.)
2.4 %
Total assets
208 bn $
Equity
86.5 bn $
Equity ratio
41.5 %
Return on equity
9 %
Cash
1.14 bn $
Operating cash flow
11.7 bn $
Free cash flow
9.08 bn $
Shares outstanding
5,699,853,733

History

Revenue by fiscal year

2016 52.8 bn $
2017 52.5 bn $
2018 40.8 bn $
2019 40.9 bn $
2020 41.7 bn $
2021 81.3 bn $
2022 101 bn $
2023 59.6 bn $
2024 63.6 bn $
2025 62.6 bn $

Net income by fiscal year

2016 7.22 bn $
2017 21.3 bn $
2018 11.2 bn $
2019 16 bn $
2020 9.16 bn $
2021 22 bn $
2022 31.4 bn $
2023 2.12 bn $
2024 8.03 bn $
2025 7.77 bn $

Dividend per share

2016 1.22 $
2017 1.30 $
2018 1.38 $
2019 1.46 $
2020 1.53 $
2021 1.57 $
2022 1.61 $
2023 1.65 $
2024 1.69 $
2025 1.72 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202562.6 bn $7.77 bn $1.36 $1.72 $11.7 bn $
202463.6 bn $8.03 bn $1.41 $1.69 $12.7 bn $
202359.6 bn $2.12 bn $0.37 $1.65 $8.7 bn $
2022101 bn $31.4 bn $5.47 $1.61 $29.3 bn $
202181.3 bn $22 bn $3.85 $1.57 $32.6 bn $
202041.7 bn $9.16 bn $1.63 $1.53 $14.4 bn $
201940.9 bn $16 bn $2.82 $1.46 $12.6 bn $
201840.8 bn $11.2 bn $1.87 $1.38 $15.8 bn $
201752.5 bn $21.3 bn $3.52 $1.30 $16.8 bn $
201652.8 bn $7.22 bn $1.17 $1.22 $16.2 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)